Trastuzumab — Mechanism of Action and Use in Clinical Practice | NEJM
Breast Cancer Treatment: Herceptin Shorter Duration
The mechanistic insights of the arrhythmogenic effect of trastuzumab - ScienceDirect
Metastatic Breast Cancer IV Infusion | PERJETA® (pertuzumab)
Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model | Scientific Reports
What Can I Expect? Late Effects of Breast Cancer Treatment - Komen Perspectives - Susan G. Komen®
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials - The Lancet Oncology
Trastuzumab treatment in patients with breast cancer and metastatic CNS disease - Annals of Oncology
Trastuzumab (Herceptin) - Oncology Nurse Advisor
Breast Cancer Drug Herceptin May Work Just As Well With Much Briefer Treatment : Shots - Health News : NPR
HERCEPTIN Dosage & Rx Info | Uses, Side Effects
Trastuzumab — Mechanism of Action and Use in Clinical Practice | NEJM
Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer - The Breast
Long-term Follow-up Data from Pivotal Studies of Adjuvant Trastuzumab in Early Breast Cancer | SpringerLink
Herceptin (Trastuzumab) Side Effects and Screening - YouTube
Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab - ScienceDirect
Targeted therapeutic options and future perspectives for HER2-positive breast cancer | Signal Transduction and Targeted Therapy
Long-Term Side Effects of Cancer Treatment | Cancer.Net
Pertuzumab in the treatment of HER2-positive breast cancer: an evidenc | CE
PPT - What's New in HER2: Current Issues in HER2 Positive Breast Cancer PowerPoint Presentation - ID:1849950
Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab - ScienceDirect
